Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.68 USD | -3.11% | -10.42% | +44.38% |
09/05 | Verastem, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
18/04 | Verastem Names John Hayslip as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.38% | 31Cr | |
+9.83% | 11TCr | |
+12.97% | 11TCr | |
-4.68% | 2.22TCr | |
-0.67% | 2.13TCr | |
-4.64% | 1.88TCr | |
-6.49% | 1.75TCr | |
-39.36% | 1.72TCr | |
+5.93% | 1.41TCr | |
+34.90% | 1.22TCr |
- Stock Market
- Equities
- VSTM Stock
- News Verastem, Inc.
- Verastem Says Ovarian Cancer Drug Combination Shows Objective Response Rate of 28% in Phase 2 Study